First Triple-negative Breast Cancer Vaccine Trial Begins
Researchers at the Cleveland Clinic have published a study on a preventive triple-negative breast cancer vaccine, the most aggressive and lethal form of this disease. The goal of this phase I trial is to determine the maximum tolerated amount of this vaccine in patients with triple-negative breast cancer in early cases. In addition, the study will serve to characterize and optimize the immune response of patients. "We hope that this […]
